Liviom

Liviom is a biotechnology company focused on the field of longevity and regenerative medicine, specifically targeting the reversal of biological aging. Founded by Dr. Michael D. West, a pioneer in stem cell research and telomere biology, the company utilizes Induced Tissue Regeneration (ITR) technology to reprogram aging cells back to a more youthful state. By modulating key transcription factors and telomerase activity, Liviom aims to develop therapies for a wide range of age-related chronic conditions, including cardiovascular and neurodegenerative diseases. The company's approach represents a shift from treating individual symptoms of aging to addressing the underlying cellular mechanisms of senescence.